In order to fulfil its mission and attain the goals, IBB undertakes essentially four types of activities:
Scientific and technological research through: (i) fundamental research to expand the boundaries of current knowledge and to ensure the development of innovative biological and chemical processes; and (ii) applied research to exploit such knowledge through the development and implementation of integrated, biological, chemical and physical processes, which are competitive, innovative, cost effective, reliable, robust, safe and well controlled, thus improving process efficiency, economy and sustainability.
Advanced education and training of a vast audience (undergraduate and postgraduate students, professionals). The IBB research units are responsible for the majority of the national Graduation courses in Biotechnology and Bioengineering. IBB participates in the PhD Programme “Bioengineering Systems” within the agreement of the Portuguese Government and the Massachusetts Institute of Technology, USA. IBB will pursuit and foster post-graduation programmes, at the Master and PhD level (2nd and 3rd cycles) in the different domains of Biotechnology and Bioengineering.
Services, consulting and technology transfer for the productive sector not only for the restructuring of the traditional chemical and biological industries (pharmaceutical, chemical, food, etc.), but also as a way of creating new opportunities in the industry and agriculture. IBB incentives the patenting, licensing, outsourcing and implementation of R&D projects in cooperation with established companies, start-ups or spin-offs. Consulting, contract research and other services (e.g. advanced analytical techniques) are made available to the biological, chemical, instrumentation and diagnosis industries.
Dissemination, scientific awareness and public perception through publication in International scientific journals and conferences and organisation of cutting-edge conferences, workshops, short courses, etc., on IBB main areas of expertise. The opportunities and benefits arising from the use of biological, chemical and biomaterials technology are also addressed and balanced against concerns over potential socio-economic and physical risks to human health and the environment.